Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-26 @ 2:07 AM
Study NCT ID:
NCT07223593
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-10-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-30
First Submit QC Date:
None
Study First Post Date:
2025-11-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL